tegafur has been researched along with Neoplasms, Squamous Cell in 7 studies
Neoplasms, Squamous Cell: Neoplasms of the SQUAMOUS EPITHELIAL CELLS. The concept does not refer to neoplasms located in tissue composed of squamous elements.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The main adverse events (AEs) of anlotinib combined with S-1 were fatigue (58." | 1.62 | Effect and safety of anlotinib combined with S-1 for recurrent or metastatic esophageal cancer patients who refused or were intolerant to intravenous chemotherapy. ( Cai, J; Liu, A; Luo, Y; Zhou, S, 2021) |
| "Widespread type 3 gastric cancer was detected in the lesser curvature." | 1.40 | [A case of advanced gastric cancer with multiple liver metastases treated with preoperative TS-1/CDDP chemotherapy and resection, with a complete response and survival for 7 years]. ( Imaida, K; Kagawa, I; Kishi, S; Matsumoto, Y; Mitan, M; Miyamoto, M; Nishiwaki, K; Saoo, K; Tsuda, H; Yokohira, M, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, J | 1 |
| Zhou, S | 1 |
| Luo, Y | 1 |
| Liu, A | 1 |
| Mitan, M | 1 |
| Miyamoto, M | 1 |
| Tsuda, H | 1 |
| Nishiwaki, K | 1 |
| Kagawa, I | 1 |
| Matsumoto, Y | 1 |
| Kishi, S | 1 |
| Yokohira, M | 1 |
| Imaida, K | 1 |
| Saoo, K | 1 |
| Kasamatsu, A | 1 |
| Uzawa, K | 1 |
| Minakawa, Y | 1 |
| Ishige, S | 1 |
| Kasama, H | 1 |
| Endo-Sakamoto, Y | 1 |
| Ogawara, K | 1 |
| Shiiba, M | 1 |
| Takiguchi, Y | 1 |
| Tanzawa, H | 1 |
| Watanabe, H | 1 |
| Itoh, H | 1 |
| Tsuchiya, Y | 1 |
| Miyagi, N | 1 |
| Sugiyama, T | 1 |
| Nakai, Y | 1 |
| Shinozaki, Y | 1 |
| Noguchi, T | 1 |
| Jinbu, Y | 1 |
| Kusama, M | 1 |
| Yoon, DH | 1 |
| Cho, Y | 1 |
| Kim, SY | 1 |
| Nam, SY | 1 |
| Choi, SH | 1 |
| Roh, JL | 1 |
| Lee, SW | 1 |
| Song, SY | 1 |
| Lee, JH | 1 |
| Kim, JS | 1 |
| Cho, KJ | 1 |
| Kim, SB | 1 |
| Kogashiwa, Y | 1 |
| Yamauchi, K | 1 |
| Nagafuji, H | 1 |
| Matsuda, T | 1 |
| Tsubosaka, T | 1 |
| Karaho, T | 1 |
| Maruyama, T | 1 |
| Kohno, N | 1 |
| Akay, S | 1 |
| Ozütemiz, O | 1 |
| Doganavsargil, B | 1 |
1 review available for tegafur and Neoplasms, Squamous Cell
| Article | Year |
|---|---|
[Reinforcement of warfarin action in a patient administered S-1].
Topics: Aged; Anticoagulants; Antimetabolites, Antineoplastic; Cardiomyopathy, Hypertrophic; Cerebral Infarc | 2015 |
1 trial available for tegafur and Neoplasms, Squamous Cell
| Article | Year |
|---|---|
Phase I study of S-1 plus nedaplatin in patients with advanced/recurrent head and neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin | 2010 |
5 other studies available for tegafur and Neoplasms, Squamous Cell
| Article | Year |
|---|---|
Effect and safety of anlotinib combined with S-1 for recurrent or metastatic esophageal cancer patients who refused or were intolerant to intravenous chemotherapy.
Topics: Antimetabolites, Antineoplastic; Drug Combinations; Esophageal Neoplasms; Humans; Indoles; Neoplasm | 2021 |
[A case of advanced gastric cancer with multiple liver metastases treated with preoperative TS-1/CDDP chemotherapy and resection, with a complete response and survival for 7 years].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Autopsy; Cisplatin; Drug Combinat | 2014 |
Decorin in human oral cancer: a promising predictive biomarker of S-1 neoadjuvant chemosensitivity.
Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Biomarkers, Tumor; Biopsy; Cell Line, Tumor | 2015 |
Usefulness of interim FDG-PET after induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck receiving sequential induction chemotherapy followed by concurrent chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Ci | 2011 |
Severe colitis after administration of UFT chemotherapy for temporal bone carcinoma.
Topics: Antineoplastic Agents; Colonic Diseases; Colonoscopy; Drug Combinations; Gastrointestinal Hemorrhage | 2004 |